Navigation Links
Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?

Erectile dysfunction (ED) is the inability of a man to achieve or maintain an erection sufficient for his sexual needs or the needs of his partner. Most men experience this at some point in their lives//, usually by age 40, and are not psychologically affected by it. Some men, however, experience chronic, complete ED (impotence), and often leads to diminished self-esteem.

According to a new study in the October 18 issue of the Journal of the American College of Cardiology, erectile dysfunction can represent an early clinical manifestation of a diffuse subclinical vascular disease and coronary artery disease is the most important problem that needs to be investigated. The smaller penile arteries suffer obstruction from plaque burden earlier than the larger coronary arteries hence ED may be symptomatic before a coronary event.

The purpose of the study, conducted in the University of Modena and Reggio Emilia, Modena, Italy, was to assess the prevalence and extent of coronary artery atherosclerosis in asymptomatic patients with vascular ED.

The researchers studied 70 patients with vascular ED, and 73 control subjects with no history of coronary artery disease. They measured traditional coronary risk factors, circulating levels of C-reactive protein (CRP), endothelial function by ultrasound of brachial artery, and coronary artery calcification by multi-slice computed tomography. The patients and the control group were similar for age, race, and coronary risk score.

The men with ED had significantly higher levels of C-reactive protein (an emerging coronary risk factor), they were more likely to have abnormal blood vessel responses to changes in blood flow (as measured by flow mediated dilation), and more of them had coronary artery calcifications detected on coronary CT scans.

The results of this study indicate that coronary atherosclerosis was found to be more severe in patients with vascular ED; ED predicts the presence a nd extent of subclinical atherosclerosis independent of traditional risk factors for cardiovascular disease. Thus, ED may be considered an additional, early warning sign of coronary atherosclerosis.

Despite the limitations of the study, it is perceived that the findings indicate erectile dysfunction should be treated as a possible signal of the early stages of atherosclerosis.
'"/>




Related medicine news :

1. Erectile dysfunction (ED) signals vascular disease
2. An Exploration into Erectile Dysfunction in Diabetics
3. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
4. Cardiovascular Disease More Common Among Erectile Dysfunction Patients
5. Erectile Dysfunction Connected To Heart Disease
6. Statins For Erectile Dysfunction- An Alternative To Viagra?
7. Erectile Dysfunction Can Be Rectified By Healthy Way Of Life
8. Host of Benefits from Erectile Dysfunction Drugs
9. Erectile Dysfunction Linked with Smoking and Obesity – Study Report
10. South Africans Turn to Natural Remedies for Treating Erectile Dysfunction
11. HIV and Erectile Medications - No Link Found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... 06, 2016 , ... The Behavioral Health Center of Excellence ... organization as a top behavioral service provider in the country. The award celebrates ... satisfaction and qualifications, and consumer satisfaction. These areas are measured via a wide-ranging ...
(Date:12/6/2016)... Cary, NC (PRWEB) , ... December 06, 2016 ... ... cancer research charity, is thrilled to formally announce its Not a Moment to ... Moment to Lose will rally supporters dedicated to declaring victory over cancer. The ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... is now offering HIAC particle counting and sizing services for USP 788 and ... instituted the new service as a response to the needs of pharmaceutical and ...
(Date:12/6/2016)... ... 06, 2016 , ... METTLER TOLEDO has launched its online ... white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user ... documents, webinars and videos available online, visit the METTLER TOLEDO Expertise Library ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble ... Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX for ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 2016  Balloon catheter is an innovative medical device ... the femoral artery in the leg or sometimes into ... blood vessels. These products are generally used to prevent ... of lipid substances in the blood vessel. In terms ... to expand at a CAGR of 3.8% during the ...
(Date:12/5/2016)... Kingdom , Dec. 5, 2016   Mallinckrodt ... global specialty pharmaceutical company, today announced that it received ... Corporate Equality Index (CEI), a national benchmarking survey and ... gay, bisexual and transgender (LGBT) workplace equality, administered by ... ranks of 517 major U.S. businesses which also earned ...
(Date:12/5/2016)...  Parallax Health Sciences, Inc. ("Parallax" or the "Company") ... pharmaceutical business, RoxSan Pharmacy, Inc. has received a license ... of the 42 states it is currently licensed to ... Pharm . D, Pharmacist in Charge at RoxSan Pharmacy, ... Medicare B spending last year came to roughly $170 ...
Breaking Medicine Technology: